Acquired factor VIII inhibitors in pregnancy: Data from the Italian Haemophilia Register relevant to clinical practice

Francesco Baudo, Francesco De Cataldo, Schiavon M. Bari, Santaro R. Catanzaro, Linari S. Firenze, Milano Niguarda, G. Mostarda, Milano Policlinico, E. Santagostino, Gamba G. Pavia, Dragani A. Pescara, Mazzucconi G. Roma, Schino P. Torino, Castaman G. Vicenza

Research output: Contribution to journalArticle

Abstract

Objective: To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy. Design: Retrospective analysis. Setting: Haemophilia and haemotology centres. Population: Patients registered and followed up at the centres. Methods: Data were collected from the Italian Haemophilia Register of acquired FVIII inhibitor. Results: Twenty of 96 cases with FVIII inhibitor were identified postpartum. The time of appearance was 3-150 days postpartum. All but one of the cases were idiopathic; 11/20 patients required blood transfusions. In six patients, the inhibitor was identified because of surgical bleeding, four after hysterectomies carried out because of postpartum haemorrhage. A prolonged activated partial thromboplastin time was present in all women in whom the test was carried out. Nine women did not require treatment because the bleeding was mild; in 11 patients bleeding was promptly controlled by different therapeutic modalities. Immunosuppressive therapy was used to suppress the inhibitor. The majority of the patients who achieved complete remission received steroids; in 6/6 patients who relapsed, a second remission was obtained with combined therapy. Conclusions: In a review of 20 pregnancies with FVIII inhibitor, over a 15 year period, bleeding was controlled in all cases with no fatalities. Correct evaluation of coagulation screening tests, in particular, activated partial thromboplastin time, is essential.

Original languageEnglish
Pages (from-to)311-314
Number of pages4
JournalBJOG: An International Journal of Obstetrics and Gynaecology
Volume110
Issue number3
DOIs
Publication statusPublished - Mar 1 2003

Fingerprint

Factor VIII
Hemophilia A
Pregnancy
Hemorrhage
Partial Thromboplastin Time
Postpartum Period
Postpartum Hemorrhage
Therapeutics
Immunosuppressive Agents
Hysterectomy
Blood Transfusion
Steroids
Population

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Acquired factor VIII inhibitors in pregnancy : Data from the Italian Haemophilia Register relevant to clinical practice. / Baudo, Francesco; De Cataldo, Francesco; Bari, Schiavon M.; Catanzaro, Santaro R.; Firenze, Linari S.; Niguarda, Milano; Mostarda, G.; Policlinico, Milano; Santagostino, E.; Pavia, Gamba G.; Pescara, Dragani A.; Roma, Mazzucconi G.; Torino, Schino P.; Vicenza, Castaman G.

In: BJOG: An International Journal of Obstetrics and Gynaecology, Vol. 110, No. 3, 01.03.2003, p. 311-314.

Research output: Contribution to journalArticle

Baudo, F, De Cataldo, F, Bari, SM, Catanzaro, SR, Firenze, LS, Niguarda, M, Mostarda, G, Policlinico, M, Santagostino, E, Pavia, GG, Pescara, DA, Roma, MG, Torino, SP & Vicenza, CG 2003, 'Acquired factor VIII inhibitors in pregnancy: Data from the Italian Haemophilia Register relevant to clinical practice', BJOG: An International Journal of Obstetrics and Gynaecology, vol. 110, no. 3, pp. 311-314. https://doi.org/10.1016/S1470-0328(03)01935-9
Baudo, Francesco ; De Cataldo, Francesco ; Bari, Schiavon M. ; Catanzaro, Santaro R. ; Firenze, Linari S. ; Niguarda, Milano ; Mostarda, G. ; Policlinico, Milano ; Santagostino, E. ; Pavia, Gamba G. ; Pescara, Dragani A. ; Roma, Mazzucconi G. ; Torino, Schino P. ; Vicenza, Castaman G. / Acquired factor VIII inhibitors in pregnancy : Data from the Italian Haemophilia Register relevant to clinical practice. In: BJOG: An International Journal of Obstetrics and Gynaecology. 2003 ; Vol. 110, No. 3. pp. 311-314.
@article{f4cbd89fcec747f88ff3cc915e5d2908,
title = "Acquired factor VIII inhibitors in pregnancy: Data from the Italian Haemophilia Register relevant to clinical practice",
abstract = "Objective: To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy. Design: Retrospective analysis. Setting: Haemophilia and haemotology centres. Population: Patients registered and followed up at the centres. Methods: Data were collected from the Italian Haemophilia Register of acquired FVIII inhibitor. Results: Twenty of 96 cases with FVIII inhibitor were identified postpartum. The time of appearance was 3-150 days postpartum. All but one of the cases were idiopathic; 11/20 patients required blood transfusions. In six patients, the inhibitor was identified because of surgical bleeding, four after hysterectomies carried out because of postpartum haemorrhage. A prolonged activated partial thromboplastin time was present in all women in whom the test was carried out. Nine women did not require treatment because the bleeding was mild; in 11 patients bleeding was promptly controlled by different therapeutic modalities. Immunosuppressive therapy was used to suppress the inhibitor. The majority of the patients who achieved complete remission received steroids; in 6/6 patients who relapsed, a second remission was obtained with combined therapy. Conclusions: In a review of 20 pregnancies with FVIII inhibitor, over a 15 year period, bleeding was controlled in all cases with no fatalities. Correct evaluation of coagulation screening tests, in particular, activated partial thromboplastin time, is essential.",
author = "Francesco Baudo and {De Cataldo}, Francesco and Bari, {Schiavon M.} and Catanzaro, {Santaro R.} and Firenze, {Linari S.} and Milano Niguarda and G. Mostarda and Milano Policlinico and E. Santagostino and Pavia, {Gamba G.} and Pescara, {Dragani A.} and Roma, {Mazzucconi G.} and Torino, {Schino P.} and Vicenza, {Castaman G.}",
year = "2003",
month = "3",
day = "1",
doi = "10.1016/S1470-0328(03)01935-9",
language = "English",
volume = "110",
pages = "311--314",
journal = "BJOG: An International Journal of Obstetrics and Gynaecology",
issn = "1470-0328",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Acquired factor VIII inhibitors in pregnancy

T2 - Data from the Italian Haemophilia Register relevant to clinical practice

AU - Baudo, Francesco

AU - De Cataldo, Francesco

AU - Bari, Schiavon M.

AU - Catanzaro, Santaro R.

AU - Firenze, Linari S.

AU - Niguarda, Milano

AU - Mostarda, G.

AU - Policlinico, Milano

AU - Santagostino, E.

AU - Pavia, Gamba G.

AU - Pescara, Dragani A.

AU - Roma, Mazzucconi G.

AU - Torino, Schino P.

AU - Vicenza, Castaman G.

PY - 2003/3/1

Y1 - 2003/3/1

N2 - Objective: To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy. Design: Retrospective analysis. Setting: Haemophilia and haemotology centres. Population: Patients registered and followed up at the centres. Methods: Data were collected from the Italian Haemophilia Register of acquired FVIII inhibitor. Results: Twenty of 96 cases with FVIII inhibitor were identified postpartum. The time of appearance was 3-150 days postpartum. All but one of the cases were idiopathic; 11/20 patients required blood transfusions. In six patients, the inhibitor was identified because of surgical bleeding, four after hysterectomies carried out because of postpartum haemorrhage. A prolonged activated partial thromboplastin time was present in all women in whom the test was carried out. Nine women did not require treatment because the bleeding was mild; in 11 patients bleeding was promptly controlled by different therapeutic modalities. Immunosuppressive therapy was used to suppress the inhibitor. The majority of the patients who achieved complete remission received steroids; in 6/6 patients who relapsed, a second remission was obtained with combined therapy. Conclusions: In a review of 20 pregnancies with FVIII inhibitor, over a 15 year period, bleeding was controlled in all cases with no fatalities. Correct evaluation of coagulation screening tests, in particular, activated partial thromboplastin time, is essential.

AB - Objective: To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy. Design: Retrospective analysis. Setting: Haemophilia and haemotology centres. Population: Patients registered and followed up at the centres. Methods: Data were collected from the Italian Haemophilia Register of acquired FVIII inhibitor. Results: Twenty of 96 cases with FVIII inhibitor were identified postpartum. The time of appearance was 3-150 days postpartum. All but one of the cases were idiopathic; 11/20 patients required blood transfusions. In six patients, the inhibitor was identified because of surgical bleeding, four after hysterectomies carried out because of postpartum haemorrhage. A prolonged activated partial thromboplastin time was present in all women in whom the test was carried out. Nine women did not require treatment because the bleeding was mild; in 11 patients bleeding was promptly controlled by different therapeutic modalities. Immunosuppressive therapy was used to suppress the inhibitor. The majority of the patients who achieved complete remission received steroids; in 6/6 patients who relapsed, a second remission was obtained with combined therapy. Conclusions: In a review of 20 pregnancies with FVIII inhibitor, over a 15 year period, bleeding was controlled in all cases with no fatalities. Correct evaluation of coagulation screening tests, in particular, activated partial thromboplastin time, is essential.

UR - http://www.scopus.com/inward/record.url?scp=0037333872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037333872&partnerID=8YFLogxK

U2 - 10.1016/S1470-0328(03)01935-9

DO - 10.1016/S1470-0328(03)01935-9

M3 - Article

C2 - 12628274

AN - SCOPUS:0037333872

VL - 110

SP - 311

EP - 314

JO - BJOG: An International Journal of Obstetrics and Gynaecology

JF - BJOG: An International Journal of Obstetrics and Gynaecology

SN - 1470-0328

IS - 3

ER -